On February 26, 2024 Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, reported that members of its management team will participate in the following sessions at two upcoming investor conferences (Press release, Syndax, FEB 26, 2024, View Source [SID1234640461]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A fireside chat at TD Cowen’s 44th Annual Health Care Conference at 9:50 a.m. ET on Monday, March 4, 2024 in Boston, MA
A corporate panel discussion on leukemia at TD Cowen’s 44th Annual Health Care Conference at 12:50 p.m. ET on Monday, March 4, 2024 in Boston, MA
A fireside chat at the Barclays Global Healthcare Conference at 8:30 a.m. ET on Tuesday, March 12, 2024 in Miami, FL
A live webcast of these sessions can be accessed from the Investor section of the Company’s website at www.syndax.com, where a replay will also be available for a limited time.